[1]JournalofChemicalResearch,2015,vol.39,#5,p.296-299
[2]EuropeanJournalofMedicinalChemistry,2013,vol.63,p.22-32
[3]ChemistryofHeterocyclicCompounds,1982,vol.18,#3,p.258-261
[4]Pharmazie,2017,vol.72,#12,p.707-713
[5]ChemistryofHeterocyclicCompounds,2009,vol.45,#10,p.1270-1275
[6]ComptesRendusChimie,2015,vol.18,#12,p.1320-1327
[7]MedicinalChemistryResearch,2016,vol.25,#1,p.1-18
[1]Pharmazie,2002,vol.57,#4,p.238-242
[2]TetrahedronLetters,2014,vol.55,#51,p.7114-7117
[3]MedChemComm,2016,vol.7,#9,p.1759-1767
[1]JournaloftheChemicalSociety,PerkinTransactions2,2001,#10,p.1989-1997
[1]ChemicalandPharmaceuticalBulletin,1985,vol.33,#9,p.3696-3708
[1]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2007/299061,2007,A1Locationinpatent:Page/Pagecolumn9-10
[2]Wenkert,E.;Moeller,P.D.;Piettre,S.R.[JournaloftheAmericanChemicalSociety,1988,vol.110,p.7188]
[3]Lee,JuYoung;Ha,Hyeri;Bae,Seri;Han,Inhyuk;Joo,JungMin[AdvancedSynthesisandCatalysis,2016,vol.358,#21,p.3458-3470]
[1]JournalofChemicalResearch,2015,vol.39,p.296-299
[2]EuropeanJournalofMedicinalChemistry,2013,vol.63,p.22-32
[3]MolecularDiversity,2020
[4]ChemistryofHeterocyclicCompounds,1982,vol.18,p.258-261
[5]Pharmazie,2017,vol.72,p.707-713
[6]ChemMedChem,2020
[7]ChemistryofHeterocyclicCompounds,2009,vol.45,p.1270-1275
[8]ComptesRendusChimie,2015,vol.18,p.1320-1327
[9]MedicinalChemistryResearch,2016,vol.25,p.1-18
[10]ChemicalPapers,2019,vol.73,p.17-25
[11]EuropeanJournalofMedicinalChemistry,2019,vol.180,p.86-98
[12]InorganicaChimicaActa,2019,vol.498
[1]Hirano,Satoshi;Akai,Ritsuko;Shinoda,Yoshihiko;Nakatsuka,Shin-ichi[Heterocycles,1995,vol.41,#2,p.255-258]
[2]Kitano,Masafumi;Kojima,Atsuyuki;Nakano,Kazuhiro;Miyagishi,Akira;Noguchi,Tsuyoshi;Ohashi,Naohito[ChemicalandPharmaceuticalBulletin,1999,vol.47,#11,p.1538-1548]
[3]Nakao,Yoshiaki;Kanyiva,KyaloStephen;Oda,Shinichi;Hiyama,Tamejiro[JournaloftheAmericanChemicalSociety,2006,vol.128,#25,p.8146-8147]
[4]Mueller,LouisG.;Chao,Allen;Alwedi,Embarek;Natrajan,Maanasa;Fleming,FraserF.[OrganicLetters,2021,vol.23,#4,p.1500-1503]
[5]Oelgen,Suereyya;Guener;Fabregat;Crespo;Nebioglu[Pharmazie,2002,vol.57,#4,p.238-242]
[6]InackNgi,Samuel;Guilloteau,Vincent;Abarbri,Mohamed;Thibonnet,Jerome[JournalofOrganicChemistry,2011,vol.76,#20,p.8347-8354]
[7]Zaienne,Daniel;Willems,Sabine;Schierle,Simone;Heering,Jan;Merk,Daniel[JournalofMedicinalChemistry,2021,vol.64,#20,p.15126-15140]
[8]CurrentPatentAssignee:VTVTHERAPEUTICSINC.-EP1532980,2005,A1Locationinpatent:Page/Pagecolumn39;41
[9]Peng,Yongle;Zhao,Zhigang;Liu,Xingli;Li,Guohua[ResearchonChemicalIntermediates,2013,vol.39,#4,p.1897-1905]
[10]Chen,Xuebing;Sun,Peng;Xu,Jinyi;Wu,Xiaoming;Kong,Lingyi;Yao,Hequan;Lin,Aijun[TetrahedronLetters,2014,vol.55,#51,p.7114-7117]
[11]CurrentPatentAssignee:YANGZHOUUNIVERSITY-CN113105460,2021,ALocationinpatent:Paragraph0142-0146
[1]Fedouloff,Michael;Hossner,Frank;Voyle,Martyn;Ranson,Jennie;Powles,Jenifer;Riley,Graham;Sanger,Gareth[BioorganicandMedicinalChemistry,2001,vol.9,#8,p.2119-2128]
[2]CurrentPatentAssignee:SERODUS-WO2005/61483,2005,A2Locationinpatent:Page/Pagecolumn53
Title: Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Journal: Bioorganic & medicinal chemistry 20120801
Title: Regioselective dibromination of methyl indole-3-carboxylate and application in the synthesis of 5,6-dibromoindoles.
Journal: Organic & biomolecular chemistry 20110721
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Enantioselective synthesis of (-)-cis-clavicipitic acid.
Journal: The Journal of organic chemistry 20071012
Title: Rolf Jansen, et al. Nannozinones and sorazinones, unprecedented pyrazinones from myxobacteria. J Nat Prod. 2014 Nov 26;77(11):2545-52.
